Hepatitis C virus infection epidemiology among people who inject drugs in Europe: a systematic review of data for scaling up treatment and prevention

Marica Ferri, , Angelos Hatzakis, Maria Prins, Peter Vickerman, Jeffrey V. Lazarus, Vivian D. Hope, Catharina Mathei

Research output: Contribution to journalArticle

124 Downloads (Pure)

Abstract

People who inject drugs (PWID) are a key population affected by hepatitis C virus (HCV). Treatment options are improving and may enhance prevention; however access for PWID may be poor. The availability in the literature of information on seven main topic areas (incidence, chronicity, genotypes, HIV co-infection, diagnosis and treatment uptake, and burden of disease) to guide HCV treatment and prevention scale-up for PWID in the 27 countries of the European Union is systematically reviewed.
Original languageEnglish
Article numbere103345
Number of pages20
JournalPLoS ONE
Volume9
Issue number7
DOIs
Publication statusPublished - 28 Jul 2014

Fingerprint

Epidemiology
Hepatitis C virus
systematic review
Virus Diseases
Viruses
Hepacivirus
epidemiology
drugs
infection
Pharmaceutical Preparations
burden of disease
European Union
Coinfection
mixed infection
HIV Infections
Genotype
Availability
incidence
genotype
Incidence

Keywords

  • people who inject drugs
  • PWID
  • hepatitis C
  • HCV epidemiology
  • Europe

Cite this

Ferri, Marica ; Hatzakis, Angelos ; Prins, Maria ; Vickerman, Peter ; Lazarus, Jeffrey V. ; Hope, Vivian D. ; Mathei, Catharina. / Hepatitis C virus infection epidemiology among people who inject drugs in Europe : a systematic review of data for scaling up treatment and prevention. In: PLoS ONE . 2014 ; Vol. 9, No. 7.
@article{3c54139b50184e21ad0e88a4d4a23f97,
title = "Hepatitis C virus infection epidemiology among people who inject drugs in Europe: a systematic review of data for scaling up treatment and prevention",
abstract = "People who inject drugs (PWID) are a key population affected by hepatitis C virus (HCV). Treatment options are improving and may enhance prevention; however access for PWID may be poor. The availability in the literature of information on seven main topic areas (incidence, chronicity, genotypes, HIV co-infection, diagnosis and treatment uptake, and burden of disease) to guide HCV treatment and prevention scale-up for PWID in the 27 countries of the European Union is systematically reviewed.",
keywords = "people who inject drugs, PWID, hepatitis C, HCV epidemiology, Europe",
author = "Lucas Weissing and Marica Ferri and Sharon Hutchinson and Bart Grady and Maria Kantzanou and Ida Sperle and Cullen, {Katelyn J.} and Angelos Hatzakis and Maria Prins and Peter Vickerman and Lazarus, {Jeffrey V.} and Hope, {Vivian D.} and Catharina Mathei",
note = "HH: 07dec15: article published but document attached to record. updated as much as possible. Author is part of the EMCDDA DRID Group, see Acknowledgements section for Contributors listing. Date of acceptance: 29/06/2014",
year = "2014",
month = "7",
day = "28",
doi = "10.1371/journal.pone.0103345",
language = "English",
volume = "9",
journal = "PLoS ONE",
issn = "1932-6203",
publisher = "PLOS",
number = "7",

}

Hepatitis C virus infection epidemiology among people who inject drugs in Europe : a systematic review of data for scaling up treatment and prevention. / Ferri, Marica; Hatzakis, Angelos; Prins, Maria; Vickerman, Peter; Lazarus, Jeffrey V.; Hope, Vivian D.; Mathei, Catharina.

In: PLoS ONE , Vol. 9, No. 7, e103345, 28.07.2014.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Hepatitis C virus infection epidemiology among people who inject drugs in Europe

T2 - a systematic review of data for scaling up treatment and prevention

AU - Weissing, Lucas

AU - Ferri, Marica

AU - Hutchinson, Sharon

AU - Grady, Bart

AU - Kantzanou, Maria

AU - Sperle, Ida

AU - Cullen, Katelyn J.

AU - Hatzakis, Angelos

AU - Prins, Maria

AU - Vickerman, Peter

AU - Lazarus, Jeffrey V.

AU - Hope, Vivian D.

AU - Mathei, Catharina

N1 - HH: 07dec15: article published but document attached to record. updated as much as possible. Author is part of the EMCDDA DRID Group, see Acknowledgements section for Contributors listing. Date of acceptance: 29/06/2014

PY - 2014/7/28

Y1 - 2014/7/28

N2 - People who inject drugs (PWID) are a key population affected by hepatitis C virus (HCV). Treatment options are improving and may enhance prevention; however access for PWID may be poor. The availability in the literature of information on seven main topic areas (incidence, chronicity, genotypes, HIV co-infection, diagnosis and treatment uptake, and burden of disease) to guide HCV treatment and prevention scale-up for PWID in the 27 countries of the European Union is systematically reviewed.

AB - People who inject drugs (PWID) are a key population affected by hepatitis C virus (HCV). Treatment options are improving and may enhance prevention; however access for PWID may be poor. The availability in the literature of information on seven main topic areas (incidence, chronicity, genotypes, HIV co-infection, diagnosis and treatment uptake, and burden of disease) to guide HCV treatment and prevention scale-up for PWID in the 27 countries of the European Union is systematically reviewed.

KW - people who inject drugs

KW - PWID

KW - hepatitis C

KW - HCV epidemiology

KW - Europe

U2 - 10.1371/journal.pone.0103345

DO - 10.1371/journal.pone.0103345

M3 - Article

VL - 9

JO - PLoS ONE

JF - PLoS ONE

SN - 1932-6203

IS - 7

M1 - e103345

ER -